Literature DB >> 27402226

T Cells Going Innate.

Midas Seyda1, Abdallah Elkhal2, Markus Quante2, Christine S Falk3, Stefan G Tullius4.   

Abstract

Natural killer (NK) cell receptors (NKRs) play a crucial role in the homeostasis of antigen-experienced T cells. Indeed, prolonged antigen stimulation may induce changes in the receptor repertoire of T cells to a profile that features NKRs. Chronic antigen exposure, at the same time, has been shown to trigger the loss of costimulatory CD28 molecules with recently reported intensified antigen thresholds of antigen-experienced CD8(+) T cells. In transplantation, NKRs have been shown to assist allograft rejection in a CD28-independent fashion. We discuss here a role for CD28-negative T cells that have acquired the competency of the NKR machinery, potentially promoting allorecognition either through T cell receptor (TCR) crossreactivity or independently from TCR recognition. Collectively, NKRs can bring about innate-like T cells by providing alternative costimulatory pathways that gain relevance in chronic inflammation, potentially leading to resistance to CD28-targeting immunosuppressants.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NK cell receptors; T cells; adaptive immunity; innate immunity; transplantation

Mesh:

Substances:

Year:  2016        PMID: 27402226      PMCID: PMC5633931          DOI: 10.1016/j.it.2016.06.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  94 in total

1.  Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.

Authors:  Jessica Strid; Scott J Roberts; Renata B Filler; Julia M Lewis; Bernice Y Kwong; William Schpero; Daniel H Kaplan; Adrian C Hayday; Michael Girardi
Journal:  Nat Immunol       Date:  2008-01-06       Impact factor: 25.606

2.  NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Authors:  Andrew Zloza; Frederick J Kohlhapp; Gretchen E Lyons; Jason M Schenkel; Tamson V Moore; Andrew T Lacek; Jeremy A O'Sullivan; Vineeth Varanasi; Jesse W Williams; Michael C Jagoda; Emily C Bellavance; Amanda L Marzo; Paul G Thomas; Biljana Zafirova; Bojan Polić; Lena Al-Harthi; Anne I Sperling; José A Guevara-Patiño
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

Review 3.  Memory T cells in transplantation - progress and challenges.

Authors:  Xian C Li; Malgosia Kloc; Rafik M Ghobrial
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

4.  Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus.

Authors:  Martijn W H J Demmers; Carla C Baan; Malou Janssen; Nicolle H R Litjens; Jan N M Ijzermans; Michiel G Betjes; Willem Weimar; Ajda T Rowshani
Journal:  Transplantation       Date:  2014-01-15       Impact factor: 4.939

5.  IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis.

Authors:  Bieke Broux; Mark R Mizee; Marjan Vanheusden; Susanne van der Pol; Jack van Horssen; Bart Van Wijmeersch; Veerle Somers; Helga E de Vries; Piet Stinissen; Niels Hellings
Journal:  J Immunol       Date:  2015-01-23       Impact factor: 5.422

6.  Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.

Authors:  Talyn Chu; Aaron J Tyznik; Sarah Roepke; Amy M Berkley; Amanda Woodward-Davis; Laura Pattacini; Michael J Bevan; Dietmar Zehn; Martin Prlic
Journal:  Cell Rep       Date:  2013-03-21       Impact factor: 9.423

7.  Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion.

Authors:  Saïdi M'Homa Soudja; Anne L Ruiz; Julien C Marie; Grégoire Lauvau
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

8.  CD160 is essential for NK-mediated IFN-γ production.

Authors:  Tony C Tu; Nicholas K Brown; Tae-Jin Kim; Joanna Wroblewska; Xuanming Yang; Xiaohuan Guo; Seoyun Hyunji Lee; Vinay Kumar; Kyung-Mi Lee; Yang-Xin Fu
Journal:  J Exp Med       Date:  2015-02-23       Impact factor: 14.307

9.  HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.

Authors:  Mathilde Allard; Pierre Tonnerre; Steven Nedellec; Romain Oger; Alexis Morice; Yannick Guilloux; Elisabeth Houssaint; Béatrice Charreau; Nadine Gervois
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness.

Authors:  Melanie Wencker; Gleb Turchinovich; Rafael Di Marco Barros; Livija Deban; Anett Jandke; Andrew Cope; Adrian C Hayday
Journal:  Nat Immunol       Date:  2013-11-17       Impact factor: 25.606

View more
  26 in total

Review 1.  Changes of T-cell Immunity Over a Lifetime.

Authors:  Yeqi Nian; Koichiro Minami; Ryoichi Maenesono; Jasper Iske; Jinrui Yang; Haruhito Azuma; Abdala ElKhal; Stefan G Tullius
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

2.  Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.

Authors:  R Kraaijeveld; G N de Graav; M Dieterich; N H R Litjens; D A Hesselink; C C Baan
Journal:  Clin Exp Immunol       Date:  2017-11-09       Impact factor: 4.330

3.  CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells.

Authors:  Xiaoyong Chen; Qiuli Liu; Andy Peng Xiang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 4.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

5.  [Analysis of the Efficacy of Immunotherapy in Elderly Patients with Lung Cancer].

Authors:  Mengjun Yu; Xiang Gao; Siyun Fu; Hui Zhang; Na Qin; Xuefeng Hao; Renjing Jin; Teng Ma; Jinghui Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-06-20

Review 6.  Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity.

Authors:  Andreas Schroeter; Maximilian J Roesel; Tomohisa Matsunaga; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

7.  An NK-like CAR T cell transition in CAR T cell dysfunction.

Authors:  Charly R Good; M Angela Aznar; Shunichiro Kuramitsu; Parisa Samareh; Sangya Agarwal; Greg Donahue; Kenichi Ishiyama; Nils Wellhausen; Austin K Rennels; Yujie Ma; Lifeng Tian; Sonia Guedan; Katherine A Alexander; Zhen Zhang; Philipp C Rommel; Nathan Singh; Karl M Glastad; Max W Richardson; Keisuke Watanabe; Janos L Tanyi; Mark H O'Hara; Marco Ruella; Simon F Lacey; Edmund K Moon; Stephen J Schuster; Steven M Albelda; Lewis L Lanier; Regina M Young; Shelley L Berger; Carl H June
Journal:  Cell       Date:  2021-12-02       Impact factor: 66.850

Review 8.  Convergence of Innate and Adaptive Immunity during Human Aging.

Authors:  Branca I Pereira; Arne N Akbar
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

9.  Divide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.

Authors:  Fernando A Arosa; André J Esgalhado; Carolina A Padrão; Elsa M Cardoso
Journal:  Front Immunol       Date:  2017-01-03       Impact factor: 7.561

10.  Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.

Authors:  Sylvain Carras; Dimitri Chartoire; Sylvain Mareschal; Maël Heiblig; Antoine Marçais; Rémy Robinot; Mirjam Urb; Roxane M Pommier; Edith Julia; Amel Chebel; Aurélie Verney; Charlotte Bertheau; Emilie Bardel; Caroline Fezelot; Lucien Courtois; Camille Lours; Alyssa Bouska; Sunandini Sharma; Christine Lefebvre; Jean-Pierre Rouault; David Sibon; Anthony Ferrari; Javeed Iqbal; Laurence de Leval; Philippe Gaulard; Alexandra Traverse-Glehen; Pierre Sujobert; Mathieu Blery; Gilles Salles; Thierry Walzer; Emmanuel Bachy; Laurent Genestier
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.